RecallGuardianCanada
Drugs· Updated December 21, 2012

Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Prosthetic Heart Valves Requiring Anticoagulant Treatment Due to their Valvular Status - For Health Professionals

Critical priority
Where it was sold

ONReported in the official notice — confirm there.

Issued by

Health Canada — Marketed health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls